Rubi Laboratories

Rubi Laboratories
Turning CO2 into cellulose for textiles using an innovative, carbon-negative enzymatic process.
About
What does Rubi Laboratories do?
Rubi Laboratories is a biotechnology startup that has developed a proprietary, cell-free biocatalytic process to convert carbon dioxide (CO2) into cellulose. This cellulose serves as a sustainable, carbon-negative alternative to wood pulp for the textile industry, enabling brands to produce lyocell and viscose fibers without contributing to deforestation or high water and land usage.
What is Rubi Laboratories's revenue?
StartupHub estimates Rubi Laboratories's annual revenue at $50.0M (range $33.0M to $113.4M, 43% confidence), based on comparable companies in the sector.
What is Rubi Laboratories's valuation?
StartupHub estimates Rubi Laboratories's effective valuation at $614.3M (range $430.0M to $798.5M, 27% confidence), based on comparable companies in the sector.
How much funding has Rubi Laboratories raised?
Rubi Laboratories has raised a total of $5M in funding. The most recent round on record is Seed.
Where is Rubi Laboratories headquartered?
Rubi Laboratories is headquartered in San Francisco, United States.
When was Rubi Laboratories founded?
Rubi Laboratories was founded in 2021.
What industry does Rubi Laboratories operate in?
Rubi Laboratories operates in Biotechnology, Materials Science, Sustainability, Textiles, Clean Technology.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.
